NRXSNeuraxis, INC

NYSE www.neuraxis.com


$ 3.00 $ -0.05 (-1.62 %)    

Friday, 17-May-2024 15:50:38 EDT
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 3.04
$ 2.94
$ 0.00 x 0
$ 0.00 x 0
$ 2.87 - $ 3.05
$ 1.80 - $ 6.93
15,349
na
9.89M
$ 1.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-16-2024 12-31-2023 10-K
2 11-20-2023 09-30-2023 10-Q
3 09-22-2023 06-30-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 earnings-scheduled-for-april-9-2024

Companies Reporting Before The Bell • Tilray Brands (NASDAQ:TLRY) is projected to report quarterly loss at $0.05 per share on ...

 neuraxis-announces-blue-cross-and-blue-shield-of-kansas-city-policy-coverage

NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromo...

 neuraxis-inc-issues-letter-to-shareholders-from-brian-carrico-president-and-chief-executive-officer

NeurAxis, Inc. (NYSE American: NRXS) ("NeurAxis" or the "Company"), a medical technology company commercializin...

 neuraxis-q3-eps-135-down-from-114-yoy-sales-47746k-down-from-61880k-yoy

Neuraxis (AMEX:NRXS) reported quarterly losses of $(1.35) per share. This is a 18.42 percent decrease over losses of $(1.14) pe...

 neuraxis-signs-exclusive-option-agreement-with-university-of-michigan-for-innovative-gastrointestinal-device

NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromo...

 neuraxis-announces-results-of-comparative-study-of-ib-stim-and-standard-medical-therapy-in-adolescents-with-functional-abdominal-pain-disorders

NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromo...

 neuraxis-q2-eps-121-down-from-087-yoy-sales-64600k-down-from-68260k-yoy

Neuraxis (AMEX:NRXS) reported quarterly losses of $(1.21) per share. This is a 39.08 percent decrease over losses of $(0.87) pe...

 why-cs-disco-are-trading-lower-by-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its...

 neuraxis-announces-over-8m-in-ib-stim-revenue

NeurAxis, Inc. (NYSE American: NRXS) ("NeurAxis" or the "Company"), a medical technology company commercializin...

 neuraxis-shares-resumed-trade
Neuraxis Shares Resumed Trade
08/09/2023 15:01:12

 neuraxis-shares-resume-trade
Neuraxis Shares Resume Trade
08/09/2023 14:52:09

 neuraxis-announces-pricing-of-6592m-initial-public-offering-of-1098667-shares-of-common-stock-at-an-price-of-6share

NeurAxis, Inc. (NYSE American: NRXS) ("NeurAxis" or the "Company"), a medical technology company commercializin...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION